Follow
Stefano Fanti
Stefano Fanti
Professore di Diagnostica per Immagini
Verified email at unibo.it
Title
Cited by
Cited by
Year
EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer—2020 update. Part 1: screening, diagnosis, and local treatment with curative intent
N Mottet, RCN van den Bergh, E Briers, T Van den Broeck, ...
European urology 79 (2), 243-262, 2021
19422021
Management of patients with advanced prostate cancer: the report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
S Gillessen, G Attard, TM Beer, H Beltran, A Bossi, R Bristow, B Carver, ...
European urology 73 (2), 178-211, 2018
833*2018
EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer. Part II—2020 update: treatment of relapsing and metastatic prostate cancer
P Cornford, RCN van den Bergh, E Briers, T Van den Broeck, ...
European urology 79 (2), 263-282, 2021
7512021
68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0
WP Fendler, M Eiber, M Beheshti, J Bomanji, F Ceci, S Cho, F Giesel, ...
European journal of nuclear medicine and molecular imaging 44, 1014-1024, 2017
7382017
Prospective comparison of 18F-fluoromethylcholine versus 68Ga-PSMA PET/CT in prostate cancer patients who have rising PSA after curative treatment and are being considered forá…
JJ Morigi, PD Stricker, PJ van Leeuwen, R Tang, B Ho, Q Nguyen, ...
Journal of nuclear medicine 56 (8), 1185-1190, 2015
6142015
Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation
E Zamagni, F Patriarca, C Nanni, B Zannetti, E Englaro, A Pezzi, ...
Blood, The Journal of the American Society of Hematology 118 (23), 5989-5995, 2011
5652011
Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE
I Virgolini, V Ambrosini, JB Bomanji, RP Baum, S Fanti, M Gabriel, ...
European journal of nuclear medicine and molecular imaging 37, 2004-2010, 2010
4922010
A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in theá…
E Zamagni, C Nanni, F Patriarca, E Englaro, P Castellucci, O Geatti, ...
Haematologica 92 (1), 50-55, 2007
4092007
Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F–DOPA
MF Bozkurt, I Virgolini, S Balogova, M Beheshti, D Rubello, C Decristoforo, ...
European journal of nuclear medicine and molecular imaging 44, 1588-1601, 2017
3992017
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015
S Gillessen, A Omlin, G Attard, JS De Bono, E Efstathiou, K Fizazi, ...
Annals of Oncology 26 (8), 1589-1604, 2015
3782015
Prognostic value of biochemical recurrence following treatment with curative intent for prostate cancer: a systematic review
T Van den Broeck, RC Van Den Bergh, N Arfi, T Gross, L Moris, E Briers, ...
European urology 75 (6), 967-987, 2019
3762019
ENETS consensus guidelines for the standards of care in neuroendocrine tumors: radiological, nuclear medicine and hybrid imaging
A Sundin, R Arnold, E Baudin, JB Cwikla, B Eriksson, S Fanti, N Fazio, ...
Neuroendocrinology 105 (3), 212-244, 2017
3732017
Role of 99mTc-DPD Scintigraphy in Diagnosis and Prognosis of Hereditary Transthyretin-Related Cardiac Amyloidosis
C Rapezzi, CC Quarta, PL Guidalotti, C Pettinato, S Fanti, O Leone, ...
JACC: Cardiovascular Imaging 4 (6), 659-670, 2011
3442011
Detection and localization of prostate cancer: correlation of 11C-choline PET/CT with histopathologic step-section analysis
M Farsad, R Schiavina, P Castellucci, C Nanni, B Corti, G Martorana, ...
Journal of Nuclear Medicine 46 (10), 1642-1649, 2005
3182005
EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands (177Lu-PSMA-RLT)
C Kratochwil, WP Fendler, M Eiber, R Baum, MF Bozkurt, J Czernin, ...
European journal of nuclear medicine and molecular imaging 46, 2536-2544, 2019
3162019
68Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate?
F Ceci, C Uprimny, B Nilica, L Geraldo, D Kendler, A Kroiss, J Bektic, ...
European journal of nuclear medicine and molecular imaging 42, 1284-1294, 2015
3072015
Detection of unknown primary neuroendocrine tumours (CUP-NET) using 68Ga-DOTA-NOC receptor PET/CT
V Prasad, V Ambrosini, M Hommann, D Hoersch, S Fanti, RP Baum
European journal of nuclear medicine and molecular imaging 37, 67-77, 2010
2992010
68Ga-DOTANOC PET/CT clinical impact in patients with neuroendocrine tumors
V Ambrosini, D Campana, L Bodei, C Nanni, P Castellucci, V Allegri, ...
Journal of Nuclear Medicine 51 (5), 669-673, 2010
2972010
Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours
V Ambrosini, P Tomassetti, P Castellucci, D Campana, G Montini, ...
European journal of nuclear medicine and molecular imaging 35, 1431-1438, 2008
2972008
Influence of trigger PSA and PSA kinetics on 11C-choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy
P Castellucci, C Fuccio, C Nanni, I Santi, A Rizzello, F Lodi, ...
Journal of Nuclear Medicine 50 (9), 1394-1400, 2009
2842009
The system can't perform the operation now. Try again later.
Articles 1–20